Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2014-11-04 12:36 |
Pharming Confirms Receipt of US$20 Million Milestone Payment from Salix Pharmac…
|
English | 46.4 KB | ||
| 2014-11-03 08:35 |
PHARMING AND SALIX ANNOUNCE THE LAUNCH OF RUCONEST® IN THE U.S. FOR THE TREATME…
|
English | 129.4 KB | ||
| 2014-10-30 12:47 |
PHARMING REPORTS ON FINANCIAL RESULTS FOR THE FIRST NINE MONTHS OF 2014
|
English | 317.0 KB | ||
| 2014-10-30 08:07 | English | 317.0 KB | |||
| 2014-10-13 08:44 |
PHARMING AND SWEDISH ORPHAN BIOVITRUM AMEND AND EXTEND RUCONEST DISTRIBUTION AG…
|
English | 67.0 KB | ||
| 2014-09-02 08:18 |
PHARMING TO SOUND THE GONG TO OPEN AMSTERDAM MARKET TO MARK A SUMMER OF SIGNIFI…
|
English | 223.0 KB | ||
| 2014-08-29 08:24 |
Pharming and Salix Announce Initiation Of Clinical Study Of RUCONEST® for Proph…
|
English | 178.9 KB | ||
| 2014-08-19 10:50 |
PHARMING ACQUIRES NEW PRODUCT LEADS THROUGH THE ACQUISITION OF CERTAIN ASSETS O…
|
English | 83.1 KB | ||
| 2014-07-31 07:24 | English | 425.3 KB | |||
| 2014-07-31 07:17 |
PHARMING REPORTS ON FINANCIAL RESULTS FIRST HALF YEAR 2014
|
English | 425.3 KB | ||
| 2014-07-17 07:06 |
PHARMING AND SALIX ANNOUNCE FDA APPROVAL OF RUCONEST® FOR THE TREATMENT OF ACUT…
|
English | 108.0 KB | ||
| 2014-06-19 06:47 |
PHARMING REPORTS ON ANNUAL GENERAL MEETING OF SHAREHOLDERS
|
English | 77.5 KB | ||
| 2014-05-15 08:26 |
PHARMING REPORTS ON FINANCIAL RESULTS FIRST QUARTER 2014
|
English | 167.2 KB | ||
| 2014-05-15 07:20 | English | 167.2 KB | |||
| 2014-04-30 18:56 | English | 1.8 MB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
